13
6
4
Cat. No. | Product Name | ||
---|---|---|---|
L7700 | 神经再生化合物库 | 524 compounds | |
524 种神经再生相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2620 | 神经退行性疾病化合物库 | 2154 compounds | |
2154 种与神经退行性疾病相关的化合物,可用于高通量和高内涵筛选; | |||
L3300 | 组胺&褪黑色素化合物库 | 153 compounds | |
153 种生物活性小分子化合物,用于高通量、高内涵筛选; | |||
L5900 | 血脑屏障通透化合物库 | 509 compounds | |
509 个 CNS-Penetrant 生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L2610 | 神经递质受体化合物库 | 1513 compounds | |
1513 种与神经递质受体相关的化合物,用于高通量、高内涵筛选; | |||
L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 237 compounds | |
237 个Wnt & Hedgehog & Notch 靶点相关的生物活性小分子化合物的特有集合,用于相关通路的研究及药物的筛选,可用于高通量、高内涵筛选。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28352 |
PDE9-IN-(S)-C33
(S)-C33 |
PDE | Metabolism |
PDE9-IN-(S)-C33 ((S)-C33) 是一种有效的选择性 PDE9 抑制剂 (IC50 = 11 nM)。 PDE9-IN-(S)-C33 可用于中枢神经系统疾病和糖尿病的相关研究。 | |||
T68079 |
Gedocarnil
ZK 113315,SH 530 |
Others | Others |
Gedocarnil(ZK 113315) 可用于研究中枢神经系统疾病。 | |||
T10881 |
CPPHA
|
GluR | Neuroscience |
CPPHA 是一种谷氨酸受体 mGluR5 和 mGluR1的 正向变构调制剂,常用于开发用于中枢神经系统疾病。 | |||
T9687 |
MAGL-IN-4
His121 ARG57 |
Lipase | Metabolism |
MAGL-IN-4 (His121 ARG57) 是选择性的、口服有效的、可透过血脑屏障的、可逆的单酰基甘油脂肪酶抑制剂,IC50=6.2 nM。它主要通过大脑中选择性抑制 MAGL 增加 2-花生四烯酰甘油水平来增强内源性大麻素信号。 | |||
T67879 |
hMAO-B-IN-5
|
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
hMAO-B-IN-5 是有一种有效的、可逆的、具有选择性的人类单胺氧化酶 hMAO-B 抑制剂( IC50 :0.12 μM)。 hMAO-B-IN-5 可以透过血脑屏障,可用于对帕金森疾病的研究,是中枢神经系统疾病的治疗和诊断中都是有潜力的化合物。 | |||
T9729 |
AGI-43192
|
Others | Others |
AGI-43192是一种有效的,可渗透进血脑屏障的蛋氨酸腺苷转移酶 2A (MAT2A) 抑制剂。AGI-43192抑制 s -腺苷蛋氨酸(SAM)生成代谢酶和蛋氨酸腺苷转移酶2A (MAT2A),具有研究 SAM 调节在中枢神经系统 (CNS) 中的作用和治疗癌症疾病的潜力。 | |||
T23440 |
TC-N 22A
|
GluR | Neuroscience |
TC-N 22A 是一种作用力强的、可选择的、口服具有活性的、可以通过血脑屏障的 mGlu4 正向别构调节剂 (PAM)。TC-N 22A 在表达人 mGlu4 的 BHK 细胞中 EC50 表现为 9 nM。TC-N 22A 在激动和正向别构模型中对 mGlu 1、2、3、5 和 7 受体的活性表现很低 (EC50 >10 μM)。TC-N 22A 可以用于中枢神经系统疾病的研究。 | |||
T10121 |
Substance P Receptor Antagonist 1
|
Others | Others |
Substance P Receptor Antagonist 1 has the potential function in gastrointestinal disorders, inflammatory diseases, respiratory, and central nervous system disorders. | |||
T79212 |
mTOR inhibitor-12
|
mTOR | PI3K/Akt/mTOR signaling |
mTORinhibitor-12(Compound 11)为选择性脑渗透性mTOR抑制剂,无遗传毒性风险,适用于中枢神经系统疾病研究。 | |||
T36813 |
Lu AE98134
|
Others | Others |
Lu AE98134, an activator of voltage-gated sodium channels, acts as a partly selective Nav1.1 channels positive modulator. Lu AE98134 also increases the activity of Nav1.2 and Nav1.5 channels but not of Nav1.4, Nav1.6 and Nav1.7 channels. Lu AE98134 can be used to analyze pathophysiological functions of the Nav1.1 channel in various central nervous system diseases, including cognitive restoring in schizophrenia, et al[1]. | |||
T62517 |
S1p receptor agonist 2
|
Others | Others |
S1p receptor agonist 2 (compound 1) 是一种 S1P5 受体的激动剂,选择性比 S1P1 和/或 S1P3 受体高。S1p receptor agonist 2 能够用于内源性 SIP 信号系统,以及减轻/预防中枢神经系统 (CNS) 疾病 (如神经退行性疾病) 的演技。 | |||
T62511 |
AZ3391
|
Others | Others |
AZ3391 是一种喹喔啉衍生物,是一种 PARP 的有效抑制剂。其中 PARP 酶家族在许多细胞过程中具有重要作用(如复制、重组、染色质重塑和 DNA 损伤修复)。AZ3391 具有潜力进行中枢神经系统组织中发生的疾病和病症的研究(如大脑和脊髓)。 | |||
T61607 |
Laquinimod sodium
|
Others | Others |
Laquinimod (ABR-215062) sodium 是一种可口服的羧酰胺衍生物,是一种有效的免疫调节剂,可防止中枢神经系统的神经变性和炎症。Laquinimod sodium 减少星形胶质细胞NF-κB 的活化以防止铜酮 (Cuprizone) 诱导的脱髓鞘。Laquinimod sodium 具有用于多发性硬化症 (MS;RRMS 或 CPMS) 的复发缓解 (RR) 和慢性进行性 (CP) 形式以及神经退行性疾病研究的潜力。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00561 |
Neurotensin Protein, Human, Recombinant (hFc)
NMN-125,NTS1,NN,NT/N,neurotensin,NT |
Human | HEK293 Cells |
NTS (Neurotensin) is a Protein Coding gene. This gene encodes a common precursor for two peptides, neuromedin N and neurotensin. NTS is a neuropeptide distributed in the central nervous and digestive systems. It belongs to the neurotensin family. NTS is an endogenous tridecapeptide of the central nervous system and the gastrointestinal tract of different mammalian species including the human. The human gene encoding neurotensin has previously been assigned to chromosome 12 but no regional locali... | |||
TMPY-03445 |
Aspartate Aminotransferase Protein, Human, Recombinant (His)
ASTQTL1,glutamic-oxaloacetic transaminase 1, soluble,cCAT,cA... |
Human | E. coli |
GOT1 (Glutamic-Oxaloacetic Transaminase 1) is a Protein Coding gene. GOT1 belongs to the class-I pyridoxal-phosphate-dependent aminotransferase family. Glutamic-oxaloacetic transaminase is a pyridoxal phosphate-dependent enzyme that exists in cytoplasmic and mitochondrial forms, GOT1 and GOT2, respectively. GOT plays a role in amino acid metabolism and the urea and tricarboxylic acid cycles. The two enzymes are homodimeric and show close homology. GOT1 is an important regulator of levels of glut... | |||
TMPY-02717 |
GPR37 Protein, Human, Recombinant (His)
hET(B)R-LP,PAELR,G protein-coupled receptor 37 (endothelin r... |
Human | HEK293 Cells |
GPR37 (cathepsin Z) is an orphan receptor that belongs to the G-protein coupled receptor 1 family. G protein-coupled receptors are a large protein family comprised of transmembrane receptors that sense molecules outside the cell and activate inside signal transduction pathways and, ultimately, cellular responses. They only exist in eukaryotes, including yeast, choanoflagellates, and animals. These receptors are bonded and activated by light-sensitive compounds, odors, pheromones, hormones, and n... | |||
TMPJ-00332 |
tPA Protein, Human, Recombinant (His)
TPA,T-PA,t-plasminogen activator,Tissue plasminogen activato... |
Human | HEK293 Cells |
Tissue-type plasminogen activator (PLAT) is a protein that secreted into extracellular space. PLAT contains five domains: EGF-like domain, fibronectin type-I domain, 2 kringle domains and peptidase S1 domain. It belongs to the peptidase S1 family. The main function of this protein is to convert plasminogen into biologically active plasmin. As a protease, PLAT plays a crucial role in regulating blood fibrinolysis, maintaining the homeostasis of extracellular matrix and in modulating the post-tra... |